Remdesivir for treating COVID-19 [ID3808]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Therapeutics for people with COVID-19 [ID4038]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC